We have initiated this newsletter to provide further industry insight and context for investors who are interested in Clover’s business activities in particular, and also in the broader bioactives and microencapsulation markets. We welcome any feedback you have on the format and content of the newsletter, including suggestions for inclusions in future issues.
Please feel free to forward this newsletter to anybody you feel may be interested, whether or not they are a shareholder of Clover Corporation Limited.
